.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,963,297

« Back to Dashboard

Details for Patent: 4,963,297

Title: Spontaneous vesticulation of multilamellar liposomes
Abstract:A new method is disclosed for making unilamellar vesicles from multilamellar vesicles. Such vesicles are formed without the use of physical of chemical disruption processes known in the art for forming unilamellar vesicles. The liposomes are incubated at neutral pH at or near the transition temperature of the lipids used, in low ionic strength media such as distilled water. The liposomes may comprise bioactive agents and may be used in vivo or in vitro.
Inventor(s): Madden; Thomas D. (Vancouver, CA)
Assignee: The Liposome Company, Inc. (Princeton, NJ)
Filing Date:Dec 22, 1987
Application Number:07/136,267
Claims:1. A method for spontaneously forming unilamellar vesicles from multilamellar vesicles comprising incubating a multilamellar lipid consisting essentially of dimyristoylphosphatidylglycerol or its admixtures with dimyristoylphosphatidylcholine in a low ionic strength medium of 50 mM salt or less at neutral pH, at about the gel-to-liquid crystalline transition temperature of the lipid until unilamellar vesicles having a particle size of about 400 nanometers or less are obtained.

2. The method of claim 1 wherein the dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol are in a 7:3 mole ratio.

3. The method of claim 2 wherein the liposomes are incubated at about 24.degree. C.

4. The method of claim 1 wherein the liposomes are incubated in medium of between about 0 mM and 25 mM salt.

5. The method of claim 4 wherein the liposomes are incubated in medium of about 10 mM salt for about 15 minutes.

6. The method of claim 1 wherein the liposomes are incubated in medium at pH of about 7.0 to about 8.0.

7. The method of claim 6 wherein the liposomes are incubated in medium at about pH 7.6.

8. The method of claim 1 wherein the multilamellar vesicles consist essentially of dimyristoylphosphatidylglycerol.

9. A method for spontaneously forming unilamellar vesicles from multilamellar vesicles comprising incubating a multilamellar lipid consisting essentially of dimyristoylphosphatidylglycerol or its admixtures with dimyristoylphosphatidylcholine in a medium of about 10 mM salt for about 15 minutes at about 24.degree. C. at pH about 7.6 until unilamellar vesicles having a particle size of about 400 nanometers or less are obtained.

10. The method of claim 9 wherein the multilamellar vesicles consist essentially of dimyristoylphosphatidylglycerol.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc